{
  "content": "Non-pharmacological rate control can also be achieved with the “pace-and-ablate” strategy, consisting of implantation of a permanent pacemaker followed by atrioventricular node ablation.\nBeta-blockers\nBeta-blockers antagonise sympathetic beta1-receptor activity in the atrioventricular node and thus slow the ventricular rate.2 Beta-blockers are most frequently used as rate-controlling agents due to their rapid onset of action, dose-dependent effect and safety profile.7",
  "source": "https://www.sciencedirect.com/science/article/pii/S266677622300220X",
  "chunk_id": "50acd98c-da40-4c26-9977-f6b1c48f7400",
  "similarity_score": 0.35330289602279663,
  "query": "beta-blockers rate control atrial fibrillation metoprolol propranolol heart rate ventricular response",
  "rank": 9,
  "title": "Atrial fibrillation: better symptom control with rate and rhythm management",
  "authors": "Dhiraj Gupta, Michiel Rienstra, Isabelle C. van Gelder, Laurent Fauchier",
  "year": "2024",
  "journal": "The Lancet Regional Health - Europe",
  "reference": "Gupta, D., Rienstra, M., van Gelder, I. C., & Fauchier, L. (2024). Atrial fibrillation: better symptom control with rate and rhythm management. The Lancet Regional Health - Europe, 37, 100801. https://doi.org/10.1016/j.lanepe.2024.100801",
  "doi": "10.1016/j.lanepe.2024.100801",
  "chunk_index": 48,
  "total_chunks": 108,
  "retrieved_at": "2025-07-24T22:33:19.809860"
}